ExperimentalMYOCARDIAL STIMULATION BY Pancuronium bromide (cas 15500-66-0)

Add time:08/29/2019    Source:sciencedirect.com

The effect of pancuronium bromide on the canine myocardium was studied by observing several indices of myocardial contractility during i.v. and intracoronary infusion of the drug in an anaesthetized, open-chested dog preparation. Pancuronium produced tachycardia when given for 2 min by i.v. and intracoronary infusion with the heart intact. Following denervation and pacing of the heart the intracoronary infusion of the drug produced increases in maximum acceleration of blood at the aortic root, peak aortic blood flow, maximum dP/dt and (maximum dP/dt)/TP. These changes occurred about 30 s after starting the infusion and returned to control values 5 min after stopping the infusion.

We also recommend Trading Suppliers and Manufacturers of Pancuronium bromide (cas 15500-66-0). Pls Click Website Link as below: cas 15500-66-0 suppliers

Prev:Original articleNeuromuscular complications in patients given pavulon/sr (Pancuronium bromide (cas 15500-66-0)) during artificial ventilation
Next:Rapid CommunicationsCOMPARATIVE POTENCY OF PIPECURONIUM BROMIDE AND Pancuronium bromide (cas 15500-66-0))